We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Software Platform Extends MS Analysis to Include Small Molecules

By HospiMedica staff writers
Posted on 05 Jun 2008
A new software platform has extended its mass spectrometry (MS) franchise to include small molecules in addition to protein analysis.

Although MS manufacturers are selling an increasing number of instruments for small molecule analysis, the bioinformatics aspect has been mostly underdeveloped. The new software program, SmileMS, offers robust, machine-independent software for the analysis of MS spectra from small molecules; a modern and dynamic user interface enabling users to seamlessly navigate through and share their results; and an open database of small molecule spectra allowing users to add both public and private data, enrich their proper search domain, and more share the database with other users.

SmileMS is a unique software platform for the identification and analysis of small molecules by liquid chromatography-mass spectrometry techniques. Developed by Geneva Bioinformatics (GeneBio; Geneva, Switzerland), in collaboration with the Swiss Institute of Bioinformatics (SIB; Geneva, Switzerland) and Prof. Denis Hochstrasser's group at Geneva University Hospitals (Geneva, Switzerland), SmileMS targets a growing need a growing need for efficient and automatable processes for routine daily analysis of small molecules.

Prof. Denis Hochstrasser said, "My lab has been thoroughly working with the GeneBio team for more than a year now and we are very happy with the quality of the results SmileMS is producing in its early version. The tool by far surpasses other tools we have tested for both the quality of its results, its user-friendliness, and most importantly its extreme flexibility; using the same tool and databases with different separation methods and instruments as well as sharing the results amongst different users through Web access show great promise for routine clinical application.”


Related Links:
Geneva University Hospitals
Geneva Bioinformatics
Swiss Institute of Bioinformatics

Gold Member
12-Channel ECG
CM1200B
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Intensive Phototherapy Unit
BC 250 LCD
New
Critical Care Ventilator
Aeros 4500

Latest Health IT News

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Strategic Collaboration to Develop and Integrate Generative AI into Healthcare

AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity